Navident 3 Receives FDA Clearance
ClaroNav Inc. announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for the 3rd generation of Navident (Navident 3), its dental surgery navigation system. This.
Industry News
Industry News
ClaroNav Secures Funding to Support Implant Technology
ClaroNav has secured quasi-equity financing from the Growth and Transition Capital team of BDC Capital, the investment arm of BDC. ClaroNav plans on.
